Access Statistics for Pierre Yves Geoffard

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Activité liée au VIH dans 24 sites hospitaliers de France métropolitaine en 1995-1996 0 0 0 0 0 0 5 6
An analysis of behaviour, health, and GDP during the Covid-19 pandemic in Europe 0 0 3 5 0 1 24 46
Anxiety Increases The Willingness To Be Exposed To Covid-19 Risk Among Young Adults In France 0 0 0 7 0 0 8 41
Anxiety Increases the Willingness the Willingness to Be Exposed to Covid-19 Risk among Young Adults in France 0 0 0 2 0 1 7 25
Anxiety Increases the Willingness the Willingness to Be Exposed to Covid-19 Risk among Young Adults in France 0 0 0 8 0 0 7 23
Anxiety increases the willingness to be exposed to covid-19 risk among young adults in France 0 0 0 0 0 0 11 20
Anxiety increases the willingness to be exposed to covid-19 risk among young adults in France 0 0 0 0 0 0 8 13
Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave 0 0 0 3 0 0 5 11
Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave 0 0 0 4 0 1 6 10
Assurance maladie en Suisse: l'assurance supplémentaire nuit-elle à la concurrence sur l'assurance de base ? 0 0 0 1 0 0 7 51
Assurance maladie en Suisse: l'assurance supplémentaire nuit-elle à la concurrence sur l'assurance de base ? 0 0 1 29 0 0 13 247
Assurance maladie en Suisse: l'assurance supplémentaire nuit-elle à la concurrence sur l'assurance de base ? 0 0 0 0 0 1 5 14
Assurance maladie: la gestion du risque long 0 0 0 0 0 0 2 1,003
Cannabis: comment reprendre le contrôle ? 0 0 0 0 0 0 1 9
Cannabis: comment reprendre le contrôle ? 0 0 0 0 0 2 5 27
Changing time and emotions 0 0 0 0 0 0 2 5
Changing time and emotions 0 0 0 10 0 0 8 51
Changing time and emotions 0 0 0 1 0 0 9 18
Changing time and emotions 0 0 0 0 1 1 13 24
Child health and access to health care in France: Evidence on the role of family income 0 0 0 0 1 1 12 17
Child health and access to health care in France: Evidence on the role of family income 0 0 0 0 0 0 7 14
Child health and use of health care services in France: Evidence on the role of family income 0 0 0 40 0 0 14 83
Child health and use of health care services in France: Evidence on the role of family income 0 0 0 19 0 0 5 26
Comment analyser le fonctionnement des systèmes de santé ? 0 0 0 0 0 1 8 22
Comment lutter contre les inégalités de santé ? 0 0 0 0 0 0 9 27
Comment meurt une épidémie ? La fin du sida en débat 0 0 0 0 1 1 2 16
Comment meurt une épidémie ? La fin du sida en débat 0 0 0 0 0 0 5 29
Comportements sexuels risques et incitations: l'impact des nouveaux traitements sur la prevention du VIH 0 0 0 42 0 0 12 688
Concurrence en santé: marché des soins, marché de l'assurance 0 0 0 0 0 0 7 10
Concurrence en santé: marché des soins, marché de l'assurance 0 0 0 0 0 0 6 17
Cost-effectiveness analysis of early access to medical and social care for migrants living with HIV in France 0 0 0 9 0 0 2 7
Cost-effectiveness analysis of early access to medical and social care for migrants living with HIV in France 0 0 1 11 0 0 7 37
Data MArkets and OPtimal Sample Size Determination 0 0 0 0 0 0 9 2,844
Decomposition of Bivariate Inequality Indicesby Attributes 0 0 0 56 0 0 17 214
Decomposition of bivariate inequality indices by attributes 0 0 0 0 0 1 9 26
Decomposition of bivariate inequality indices by attributes 0 0 0 0 1 1 8 40
Decomposition of bivariate inequality indices by attributes 0 0 0 12 0 0 9 78
Decomposition of bivariate inequality indices by attributes 0 0 0 2 0 0 5 17
Discouting and Optimizing Capital Accumulation as a Variational Minmax Problem 0 0 0 0 0 0 5 286
Disease Eradication: Private vs. Public Vaccination 0 0 0 0 0 1 7 575
Dépenses de santé: l'hypothèse d'aléa moral 0 0 0 0 0 3 14 638
Economic and public health consequences of delayed access to medical care for migrants living with HIV in France 0 0 0 0 0 0 10 45
Economic and public health consequences of delayed access to medical care for migrants living with HIV in France 0 0 0 0 0 1 5 18
End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported 0 0 0 1 0 0 5 31
End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported 0 0 0 0 1 1 16 97
Family income and child health in the UK 0 0 0 0 0 2 11 25
Family income and child health in the UK 0 0 0 40 0 0 7 103
Family income and child health in the UK 0 0 0 0 0 0 6 21
Family income and child health in the UK 0 0 0 3 0 0 9 34
Gérer le risque de dépendance 0 0 0 0 0 0 2 23
Gérer le risque de dépendance 0 0 0 0 0 0 4 6
Incentive and Selection Effects in Health Insurance 0 0 0 0 0 1 11 39
L'économie du reste à charge 0 0 0 0 0 0 3 7
L'économie du reste à charge 0 0 0 0 0 0 8 23
L'équité dans le financement du système d'indemnisation: quelques éléments de réflexion, beaucoup d'incertitudes 0 0 0 0 0 0 4 15
La concurrence, c'est l'innovation ? 0 0 0 0 0 0 7 13
La concurrence, c'est l'innovation ? 0 0 0 0 0 0 5 28
La demande de prévention est-elle induite par l'offre ? 0 0 0 0 0 0 7 23
La demande de prévention est-elle induite par l'offre ? 0 0 0 0 1 1 10 27
La demande de prévention est-elle induite par l'offre ? 0 0 0 0 0 0 2 10
La lancinante réforme de l'assurance maladie 0 0 0 0 0 0 7 58
La réception d'une note du Conseil d'Analyse Économique relative à la légalisation du cannabis 0 0 0 1 0 1 10 11
La réception d'une note du Conseil d'Analyse Économique relative à la légalisation du cannabis 0 0 0 3 0 1 3 8
La régulation des dépenses de santé: comment faire ? 0 0 0 0 0 0 6 18
La régulation des dépenses de santé: comment faire ? 0 0 0 0 0 1 5 13
La régulation des secteurs de la santé: volume 6 0 0 0 0 0 0 9 34
La régulation des secteurs de la santé: volume 6 0 0 0 0 0 0 8 10
La régulation des secteurs de la santé: volume 6 0 0 0 0 0 2 7 15
La santé par quels moyens et à quels prix ? 0 0 0 0 0 1 5 8
La santé par quels moyens et à quels prix ? 0 0 0 0 0 1 7 37
La santé, par quels moyens et à quels prix ? 0 0 0 0 0 0 5 12
La santé, par quels moyens et à quels prix ? 0 0 0 0 0 0 3 11
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 0 1 0 3 20 42
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 0 1 0 3 11 23
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 0 1 0 1 8 25
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 0 3 0 0 6 44
L’AMO ne suffit plus à garantir un accès aux soins sans barrière financière 0 0 0 0 0 0 4 16
L’AMO ne suffit plus à garantir un accès aux soins sans barrière financière 0 0 0 0 1 1 11 27
Measuring Well Being Inequality 0 0 0 0 0 0 7 17
Measuring Well Being Inequality 0 0 0 0 0 0 2 6
Medical Spending in France: Concentration, Persistence and Evolution before Death 0 0 0 0 0 0 4 12
Medical Spending in France: Concentration, Persistence and Evolution before Death 0 0 0 0 0 0 1 26
Moral Hazard and the Demand for Physician Services: First Lessons from a French Natural Experiment 0 0 0 0 0 1 23 2,178
Parents' education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 20 0 0 8 77
Parents' education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 22 0 0 39 126
Parents' education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 27 0 0 13 27
Parents’ education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 0 0 0 10 24
Parents’ education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 0 0 1 17 36
Peut-on evaluer le cout d'une maladie? 0 0 0 0 0 0 10 283
Politique de santé et inégalités sociales 0 0 0 0 0 3 9 12
Politique de santé et inégalités sociales 0 0 0 0 0 0 11 30
Politiques de santé en Europe et inégalités sociales 0 0 0 0 0 0 5 18
Politiques de santé et inégalités sociales en Europe 0 0 0 0 0 0 8 20
Pour un système de santé plus efficace 0 1 1 33 0 1 4 93
Pour un système de santé plus efficace 0 0 0 0 1 2 7 29
Pricing and R&D with Related Margins 0 0 0 0 0 0 8 571
Quelle assurance contre le risque dépendance ? 0 0 0 0 0 0 7 11
Quelle assurance contre le risque dépendance ? 0 0 0 0 0 0 12 20
Quelles formes de concurrence en assurance santé ? 0 0 0 0 0 0 4 32
Quelles sont les perspectives ouvertes par l’exploitation des données administratives ? 0 0 0 0 0 0 4 10
Quelles sont les perspectives ouvertes par l’exploitation des données administratives ? 0 0 0 0 0 0 5 18
Rational Epidemics and their Public Control 0 0 0 0 0 1 14 646
Refonder l'assurance-maladie 0 0 0 10 1 2 4 52
Refonder l’assurance-maladie 0 0 0 0 0 0 4 11
Refonder l’assurance-maladie 0 0 0 0 0 1 3 26
Reforming Incentive Schemes Under Political Constraints: The Physician Agency 0 0 0 103 0 1 10 416
Reforming incentive schemes under political constraints: The physician agency 0 0 0 5 0 0 2 58
Reforming incentive schemes under political constraints: The physician agency 0 0 0 91 0 2 39 339
Reforming incentive schemes under political contraints: The physician agency 0 0 0 0 0 0 8 25
Santé: l'heure des choix 0 0 0 0 0 0 5 16
Santé: l'heure des choix 0 0 0 0 0 0 7 37
Scared by Foreigners and their Products? Survey Evidence from France 0 0 0 68 0 1 14 369
Separating Selection and Incentive Effects in Health Insurance 0 0 0 143 0 1 15 445
Separating Selection and Incentive Effects: an Econometric Study of Swiss Health Insurance Claims Data 0 0 0 314 0 1 11 1,085
Separating Selection and Incentive Effects: an Econometric Study of Swiss Health Insurance Claims Data 0 0 0 0 0 1 8 56
Separating selection and incentive effects in health insurance 0 0 0 7 0 1 8 40
Separating selection and incentive effects in health insurance 0 0 1 31 0 1 10 133
Socio-economic inequalities in access to COVID-19 tests in France in 2020: evidence from the EPICOV socio-epidemiological cohort 0 0 0 0 0 1 6 6
Socio-economic inequalities in access to COVID-19 tests in France in 2020: evidence from the EPICOV socio-epidemiological cohort 0 0 1 1 0 3 12 12
Sunspot Fluctuations around a Steady State: The Case of Multidimensional One-Step forward Looking Economic Models 0 0 0 0 0 1 12 390
The Transmission of Information through Prices: an Alternative Exploratory Assessment of Market Performance 0 0 0 0 0 0 5 251
The influence of supplementary health insurance on switching behaviour: evidence from Swiss data 0 0 0 0 0 0 6 11
The influence of supplementary health insurance on switching behaviour: evidence from Swiss data 0 0 0 0 3 4 17 55
The influence of supplementary health insurance on switching behaviour: evidence on Swiss data 0 0 1 13 1 1 11 164
The influence of supplementary health insurance on switching behaviour: evidence on Swiss data 0 0 0 2 0 0 7 40
The subjective value of a life with Down syndrome: Evidence from amniocentesis decision 0 0 0 0 0 0 5 11
The subjective value of a life with Down syndrome: Evidence from amniocentesis decision 0 0 0 0 0 1 7 22
The subjective value of a life with Down syndrome: Evidence from amnocentesis decision 0 0 0 0 0 0 7 9
The subjective value of a life with Down syndrome: Evidence from amnocentesis decision 0 0 0 2 0 0 8 19
The subjective value of a life with Down syndrome: Evidence from amnocentesis decision 0 0 0 0 0 1 21 29
Therapeutic non adherence: A rational behavior revealing patient preferences? 0 0 0 0 1 1 10 17
Therapeutic non adherence: A rational behavior revealing patient preferences? 0 0 0 1 3 3 11 57
Therapeutic non adherence: a rational behavior revealing patient preferences ? 0 0 0 4 0 1 9 46
Therapeutic non adherence: a rational behavior revealing patient preferences ? 0 0 0 23 0 1 37 199
Workplace smoking ban effects in an heterogeneous smoking population 0 0 0 47 0 1 5 139
Workplace smoking ban effects in an heterogeneous smoking population 0 0 0 2 0 1 10 30
Workplace smoking ban effects on unhappy smokers 0 0 0 0 0 0 11 54
Workplace smoking ban effects on unhappy smokers 0 0 0 0 0 0 8 14
À quoi peut servir la concurrence en assurance santé ? 0 0 0 10 0 1 11 64
Total Working Papers 0 1 9 1,294 17 79 1,208 17,424
16 registered items for which data could not be found

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
5. Quelles sont les perspectives ouvertes par l’exploitation des données administratives ? 0 0 0 0 1 1 11 15
A quoi peut servir la concurrence en assurance santé ? 0 0 0 9 0 0 9 69
Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave 0 0 0 0 0 0 5 9
Assurance maladie en Suisse: les assurances supplémentaires nuisent-elles à la concurrence sur l'assurance de base ? 0 0 0 6 1 1 7 91
Comportements sexuels risqués et incitations. L'impact des nouveaux traitements sur la prévention du vih 0 0 0 7 0 0 14 146
Concurrence en santé: marché des soins, marché de l'assurance 0 0 0 3 0 0 7 19
Decomposition of bivariate inequality indices by attributes 0 0 0 45 1 1 14 156
Discounting and Optimizing: Capital Accumulation Problems as Variational Minmax Problems 0 0 0 30 0 1 21 152
Disease Eradication: Private versus Public Vaccination 0 1 9 424 2 4 34 1,080
Do Prices Transmit Rationally Expected Information? 0 0 0 93 0 2 27 406
Dépenses de santé: l'hypothèse d'aléa moral 0 0 0 23 0 2 9 154
Economic and public health consequences of delayed access to medical care for migrants living with HIV in France 0 0 0 4 1 3 16 40
Efficient and equilibrium allocations with stochastic differential utility 0 0 2 100 0 2 13 203
Family income and child health in the UK 0 0 0 42 0 1 12 181
Gérer le risque de dépendance 0 0 0 0 0 0 7 14
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 0 7 1 3 11 64
Medical Spending in France: Concentration, Persistence and Evolution before Death 0 0 0 4 0 1 9 27
Moral hazard and the demand for physician services: First lessons from a French natural experiment 0 0 5 380 0 0 26 839
Parents’ education and child body weight in France: The trajectory of the gradient in the early years 0 0 1 6 0 0 12 80
Pricing and R&D When Consumption Affects Longevity 0 0 0 0 0 0 5 204
Quelle assurance contre le risque dépendance ? 0 0 0 0 2 6 8 11
Rational Epidemics and Their Public Control 0 0 0 1 0 3 28 713
Reforming incentive schemes under political constraints: the physician agency 0 0 0 4 0 1 15 39
Réformer le système de remboursement pour les soins de ville, une analyse par microsimulation 0 0 0 5 0 1 5 54
Sunspot Fluctuations around a Steady State: The Case of Multidimensional, One-Step Forward Looking Economic Models 0 0 0 70 0 0 8 361
The influence of supplementary health insurance on switching behaviour: evidence from Swiss data 0 0 1 38 1 1 11 299
The subjective value of a life with Down syndrome: Evidence from amniocentesis decision 0 0 0 3 0 2 14 45
Therapeutic non‐adherence: a rational behavior revealing patient preferences? 1 1 1 1 2 2 14 27
Workplace smoking ban effects on unhappy smokers 0 0 0 3 0 1 11 134
Total Journal Articles 1 2 19 1,308 12 39 383 5,632

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Incentive and Selection Effects in Health Insurance 0 0 0 25 0 0 7 74
Incentive and Selection Effects in Health Insurance 0 0 0 14 0 0 14 56
Total Chapters 0 0 0 39 0 0 21 130

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-08-07